NASDAQ

Neuronetics, Inc. (STIM)

559 Thanks from members

Neuronetics, Inc. (STIM) exhibits highly volatile, speculative turnaround sentiment driven by strong Q2 revenue beats, Greenbrook clinic expansion, and widened provider access, offset by ongoing cash burn, debt covenant pressures, and a low market penetration rate.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →